Services
Expertises
Resources
Who we are
Closed

Advancing Technologies for Spatiotemporal Omics in Live Tissue

Live-tissue omics technology development

Funding available
$ 500,000 - $ 1,000,000
Up to 15% of project cost
Deadline
Unspecified
Location
Canada
Who can apply
Nonprofit organizations
See full eligibility

Overview

Supports two-year research projects developing live-tissue technologies for real-time spatial proteomic and metabolomic analysis. Funding is available for Focused Projects up to $500,000 USD and Expanded Projects up to $1,000,000 USD, including eligible activities in immunology and autoimmune disease research.

At a glance

Funding available

Maximum funding
$1,000,000
Minimum funding
$500,000
Maximum share of project costs
15%
Financing goals
  • Increase performance through digital transformation
  • Develop strategic partnerships
  • Develop team skills
  • Develop a new product or service
  • Conduct research and development activities
  • Strengthen organizational capacity
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
Non-profit, Public or Parapublic institution
Non-profit candidates
Sector of operation
Higher Education, Research, Hospitals and Rehabilitation

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2026
Periods: 1

Eligibility

Who is eligible?

  • Nonprofit organizations
  • Colleges and universities
  • Hospitals and laboratories
  • State and local government units
  • Eligible federal government agencies

Who is not eligible

  • For-profit organizations receiving funding
  • Meta employees and employees of subsidiary Meta entities
  • Employees of Chan Zuckerberg Initiative, LLC
  • Employees of Chan Zuckerberg Biohub, Inc.

Eligible expenses

  • Personnel costs
  • Supplies and equipment
  • Travel and meeting-related costs
  • Subcontracts and other project costs
  • Indirect costs up to 15%

Ineligible Costs and Activities

  • Travel expenses to the United States for international grantees
  • Indirect costs on capital equipment
  • Indirect costs on subcontracts

Eligible geographic areas

  • Domestic and foreign organizations
  • Applicants from any country, subject to compliance requirements

Activities funded

  • Development of live-tissue technologies for real-time spatial proteomic and metabolomic profiling.
  • Engineering and validation of instrumented tissue systems for immune monitoring.
  • Creation of integrated sampling and detection platforms for longitudinal analysis.
  • Development of computational tools for real-time spatial mapping and data interpretation.

How to apply

  • Step 1: Prepare the application materials
    • Complete the required portal tasks for the Coordinating PI, organization, project details, proposal, budget, and biosketches.
    • Gather the optional letters of commitment from Co-PIs if desired.
  • Step 2: Submit through the online portal
    • Register or log in at the CZI grants portal.
    • Open the program page and click Apply.
    • Enter the application title and complete all required sections.
    • Submit the application by November 13, 2025 at 2 p.m. PT / 5 p.m. ET.

Documents Needed

  • Institutional Approval Form
  • Project Proposal
  • Budget
  • Biosketches for the Coordinating PI and Co-PIs
  • Optional Letters of Commitment from Co-PIs

Selection criteria

  • Scientific and technical merit
  • Investigator qualifications
  • Potential impact
  • Collaborative and institutional support
  • Budget justification

Processing and Agreement

  • Applications are reviewed for scientific merit and eligibility.
  • Independent expert review is used in the evaluation process.
  • Final decisions are made by CZI and Biohub Network staff with scientific advisors.
  • Applicants are notified of decisions in late February 2026, subject to change.
  • Selected projects require ongoing progress and financial reporting.

Additional information

  • Up to three PIs per application.
  • Institutional approval form required.
  • Annual progress reports are required.

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Advancing Technologies for Spatiotemporal Omics in Live Tissue Program

What is the Advancing Technologies for Spatiotemporal Omics in Live Tissue?

Supports two-year research projects developing live-tissue technologies for real-time spatial proteomic and metabolomic analysis. Funding is available for Focused Projects up to $500,000 USD and Expanded Projects up to $1,000,000 USD, including eligible activities in immunology and autoimmune disease research.

How much funding can be received?

Advancing Technologies for Spatiotemporal Omics in Live Tissue Funds up to 15% of admissible expenses, capped at $1,000,000 per project.

Who is eligible for the Advancing Technologies for Spatiotemporal Omics in Live Tissue program?

To be eligible for the Advancing Technologies for Spatiotemporal Omics in Live Tissue program, you must: Nonprofit or institutional applicants Lead PI tied to host institution Up to three PIs per application

What expenses are eligible under Advancing Technologies for Spatiotemporal Omics in Live Tissue?

Personnel costs Supplies and equipment Travel and meeting-related costs Subcontracts and other project costs Indirect costs up to 15%

Who can I contact for more information about the Advancing Technologies for Spatiotemporal Omics in Live Tissue?

You can contact Chan Zuckerberg Initiative (CZI) by email at sciencegrants@chanzuckerberg.com.

Where is the Advancing Technologies for Spatiotemporal Omics in Live Tissue available?

The Advancing Technologies for Spatiotemporal Omics in Live Tissue program is available across Canada.

Is the Advancing Technologies for Spatiotemporal Omics in Live Tissue a grant, loan, or tax credit?

Advancing Technologies for Spatiotemporal Omics in Live Tissue is a Grant and Funding